Large-cap Consumer Staples company CVS Health has moved 0.1% so far today on a volume of 757,819, compared to its average of 8,115,731. In contrast, the S&P 500 index moved 0.0%.
CVS Health trades -21.99% away from its average analyst target price of $90.16 per share. The 22 analysts following the stock have set target prices ranging from $76.0 to $110.0, and on average have given CVS Health a rating of buy.
Anyone interested in buying CVS should be aware of the facts below:
-
CVS Health's current price is 27.5% above its Graham number of $55.18, which implies that at its current valuation it does not offer a margin of safety
-
CVS Health has moved -29.0% over the last year, and the S&P 500 logged a change of 18.0%
-
Based on its trailing earnings per share of 6.53, CVS Health has a trailing 12 month Price to Earnings (P/E) ratio of 10.8 while the S&P 500 average is 15.97
-
CVS has a forward P/E ratio of 8.2 based on its forward 12 month price to earnings (EPS) of $8.6 per share
-
The company has a price to earnings growth (PEG) ratio of 1.97 — a number near or below 1 signifying that CVS Health is fairly valued compared to its estimated growth potential
-
Its Price to Book (P/B) ratio is 1.22 compared to its sector average of 4.29
-
CVS Health Corporation provides health services in the United States.
-
Based in Woonsocket, the company has 219,000 full time employees and a market cap of $90.51 Billion. CVS Health currently returns an annual dividend yield of 3.4%.